Glucose Dependent Insulinotropic Receptor (G Protein Coupled Receptor 119 or GPR119) - Pipeline Review, H2 2016
"Glucose
Dependent Insulinotropic Receptor (G Protein Coupled Receptor 119 or
GPR119) - Pipeline Review, H2 2016"
The Report covers current Market Trends, Analysis, Forecast, Review,
Share, Size, Growth, Effect.
Description-
Summary
Global
Markets Directs, Glucose Dependent Insulinotropic Receptor (G Protein
Coupled Receptor 119 or GPR119) - Pipeline Review, H2 2016, provides
in depth analysis on Glucose Dependent Insulinotropic Receptor (G
Protein Coupled Receptor 119 or GPR119) targeted pipeline
therapeutics.
The
report provides comprehensive information on the Glucose Dependent
Insulinotropic Receptor (G Protein Coupled Receptor 119 or GPR119) ,
targeted therapeutics, complete with analysis by indications, stage
of development, mechanism of action (MoA), route of administration
(RoA) and molecule type. The report also covers the descriptive
pharmacological action of the therapeutics, its complete research and
development history and latest news and press releases. Additionally,
the report provides an overview of key players involved in Glucose
Dependent Insulinotropic Receptor (G Protein Coupled Receptor 119 or
GPR119) targeted therapeutics development and features dormant and
discontinued projects.
Scope
-
The report provides a snapshot of the global therapeutic landscape
for Glucose Dependent Insulinotropic Receptor (G Protein Coupled
Receptor 119 or GPR119)
-
The report reviews Glucose Dependent Insulinotropic Receptor (G
Protein Coupled Receptor 119 or GPR119) targeted therapeutics under
development by companies and universities/research institutes based
on information derived from company and industry-specific sources
Reasons
to buy
-
Gain strategically significant competitor information, analysis, and
insights to formulate effective R&D strategies
-
Identify emerging players with potentially strong product portfolio
and create effective counter-strategies to gain competitive advantage
-
Identify and understand the targeted therapy areas and indications
for Glucose Dependent Insulinotropic Receptor (G Protein Coupled
Receptor 119 or GPR119)
-
Identify the use of drugs for target identification and drug
repurposing
-
Identify potential new clients or partners in the target demographic
Comments
Post a Comment